Cullinan Therapeutics, Inc. ($CGEM)
Filing Information
| Accession Number | 0001193125-26-002687 |
|---|---|
| Form Type | 4 |
| Filing Date | Jan 5, 2026 |
| Document Date | Dec 31, 2025 |
| Document | View SEC Filing |
Transactions
1
Total Shares
27
Total Value
$175.23
P&L
+107.9% (+$189.00)
Transactions
| Name | Title | Security | Derivative | Transaction Date | Type | Shares | Price | Total Cost | Shares After | Direct/Indirect | Nature of Ownership | Actions |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
Chief Financial Officer | Common Stock | โ | Dec 31, 2025 | Grant/Award | 27 | $6.49 | $175.23 | 62,028 | Direct | โ | View Details |